MAPT and Alzheimer disease: The rates of change of hippocampal tau PET SUVr (increases in the range ∼0.1‐0.5 over 6 months) and hippocampal GM loss (decreases in the range ∼5‐20% in 6 months) are both substantially greater than those observed in sporadic human AD.